Use access key #2 to skip to page content.
$9.22 1.91 (26.13%)
10/13/2008 4:02 PM

Boston Scientific Corp. (BSX)

CAPS Rating:
***

The Company develops, manufactures & markets medical devices that are used in interventional cardiology, peripheral interventions, vascular surgery, electrophysiology, neurovascular intervention, oncology, endoscopy, urology, gynecology & neuromodulation.

View All Commentary (BSX)

Recs

2

Avatar 5761 (< 20) Submitted: 10/22/07 9:13 AM : Outperform Start Price: $14.29 BSX Score: 4.10

finally cleaning up expenses and head count which should have been done 12 months ago. Management was a little slow in getting started but they seem to "get it" now. Debt will come down and non strategic businesses will be sold. Coated stents will slowly recover market. Main issue left to resolve is FDA letter.

Report this Post Replies: 0 | Reply

Featured Broker Partners